Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
7.61
+0.02 (0.26%)
At close: Nov 11, 2026, 4:00 PM EST
7.63
+0.02 (0.26%)
After-hours: Nov 11, 2026, 7:30 PM EST
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $469.78 million as of November 11, 2026. It is the 14,917th most valuable company in the world and the 2,771st biggest in the United States. Its market cap has decreased by 58.15% in one year.
Market Cap
469.78M
Enterprise Value
221.08M
1-Year Change
-58.15%
Global Rank
Country Rank
#2,771 United States
Category
ChartMarket Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $469.78M, an increase of 195.34%. That is a compound annual growth rate of 21.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 469.78M | -59.31% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 519.84M |
| Electra Therapeutics | 508.73M |
| Shattuck Labs | 508.19M |
| Gyre Therapeutics | 501.29M |
| Monopar Therapeutics | 492.07M |
| Eupraxia Pharmaceuticals | 487.98M |
| MiMedx Group | 485.20M |
| YD Bio | 483.07M |